ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
178 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
75% less call options, than puts
Call options by funds: $24.3M | Put options by funds: $96.7M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
178
Holding in Top 10
–
Calls
$24.3M
Puts
$96.7M
Top Buyers
| 1 | +$135M | |
| 2 | +$21.8M | |
| 3 | +$17.5M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$13M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$10.9M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$15M | |
| 3 | -$13.5M | |
| 4 |
BC
Broadfin Capital
New York
|
-$12.1M |
| 5 |
AC
Armistice Capital
New York
|
-$8.05M |